(VIANEWS) – Sierra Bancorp (BSRR), Inter Parfums (IPAR), The Descartes Systems Group (DSGX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Sierra Bancorp (BSRR)
97.4% sales growth and 10.85% return on equity
Sierra Bancorp operates as the bank holding company for Bank of the Sierra that provides retail and commercial banking services to individuals and businesses in California. The company accepts various deposit products, such as checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. Its loan products include agricultural, commercial, consumer, real estate, construction, and mortgage loans. The company also offers automated teller machines; electronic point-of-sale payment alternatives; online and automated telephone banking services; and remote deposit capture and automated payroll services for business customers. As of December 31, 2021, it operated 35 full-service branches, an online branch, a loan production office, an agricultural credit center, and an SBA center. Sierra Bancorp was founded in 1977 and is headquartered in Porterville, California.
Earnings Per Share
As for profitability, Sierra Bancorp has a trailing twelve months EPS of $2.45.
PE Ratio
Sierra Bancorp has a trailing twelve months price to earnings ratio of 12.1. Meaning, the purchaser of the share is investing $12.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.85%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 7.4% and 67.4%, respectively.
Yearly Top and Bottom Value
Sierra Bancorp’s stock is valued at $29.64 at 16:22 EST, under its 52-week high of $31.85 and way higher than its 52-week low of $16.75.
2. Inter Parfums (IPAR)
13.6% sales growth and 19.94% return on equity
Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, and Ungaro brands, as well as French Connection, Intimate, and Aziza names. It sells its products to department stores, specialty stores, duty free shops, beauty retailers, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Inter Parfums has a trailing twelve months EPS of $4.39.
PE Ratio
Inter Parfums has a trailing twelve months price to earnings ratio of 27.43. Meaning, the purchaser of the share is investing $27.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.94%.
Moving Average
Inter Parfums’s worth is below its 50-day moving average of $126.51 and below its 200-day moving average of $130.37.
Sales Growth
Inter Parfums’s sales growth is 12.4% for the ongoing quarter and 13.6% for the next.
Yearly Top and Bottom Value
Inter Parfums’s stock is valued at $120.43 at 16:22 EST, way below its 52-week high of $156.75 and way above its 52-week low of $108.39.
Volume
Today’s last reported volume for Inter Parfums is 5629 which is 96.18% below its average volume of 147588.
3. The Descartes Systems Group (DSGX)
12.1% sales growth and 10.28% return on equity
The Descartes Systems Group Inc. provides cloud-based logistics and supply chain management solutions worldwide. Its Logistics Technology platform offers a range of modular, interoperable web and wireless logistics management solutions. The company provides a suite of solutions that include routing, mobile, and telematics; transportation management; ecommerce, shipping, and fulfillment; customs and regulatory compliance; global trade intelligence; broker and forwarder enterprise systems; and B2B messaging and connectivity services. It also offers its customers to use its modular, software-as-a-service, and data solutions to route, schedule, track, and measure delivery resources; plan, allocate, and execute shipments; rate, audit, and pay transportation invoices; access and analyze global trade data; research and perform trade tariff and duty calculations; file customs and security documents for imports and exports; and various other logistics processes. In addition, the company provides consulting, implementation, and training services, as well as maintenance and support services. It serves transportation providers, such as air, ocean, and truck modes; logistics service providers, including third-party logistics providers, freight forwarders, and customs brokers; and distribution-intensive companies, such as manufacturers, retailers, distributors, and mobile business service providers through subscription, transactional or perpetual license basis. The Descartes Systems Group Inc. was incorporated in 1981 and is headquartered in Waterloo, Canada.
Earnings Per Share
As for profitability, The Descartes Systems Group has a trailing twelve months EPS of $1.48.
PE Ratio
The Descartes Systems Group has a trailing twelve months price to earnings ratio of 66.95. Meaning, the purchaser of the share is investing $66.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.28%.
Yearly Top and Bottom Value
The Descartes Systems Group’s stock is valued at $99.09 at 16:22 EST, below its 52-week high of $104.71 and way above its 52-week low of $69.59.
Volume
Today’s last reported volume for The Descartes Systems Group is 120251 which is 10.26% below its average volume of 134003.
4. STAAR Surgical Company (STAA)
5.4% sales growth and 4.36% return on equity
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Earnings Per Share
As for profitability, STAAR Surgical Company has a trailing twelve months EPS of $0.33.
PE Ratio
STAAR Surgical Company has a trailing twelve months price to earnings ratio of 92.09. Meaning, the purchaser of the share is investing $92.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.36%.
Volume
Today’s last reported volume for STAAR Surgical Company is 1436860 which is 79.91% above its average volume of 798636.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 43.3% and a negative 46.2%, respectively.
Moving Average
STAAR Surgical Company’s value is way under its 50-day moving average of $36.54 and way below its 200-day moving average of $37.54.
Sales Growth
STAAR Surgical Company’s sales growth is 8.6% for the ongoing quarter and 5.4% for the next.
